News | April 27, 2026
NIT Rourkela secures patent for rapid spice adulteration detection system
FTIR and machine learning-based technology enables real-time, cost-effective quantification of food adulterants
FTIR and machine learning-based technology enables real-time, cost-effective quantification of food adulterants
Former Cipla MD & CEO to lead next phase of growth at science-led CDMO platform; Vivek Sharma transitions to advisory role
New minimally invasive biomarker test enables earlier diagnosis and improved clinical decision-making, aligned with global guidelines
Multidisciplinary team expansion brings integrated medical, surgical, and radiation oncology services under one roof
Our company is prioritising deeper collaborations with CDMOs and biosimilar companies as part of its strategy to expand its footprint across India, Middle East, and Africa region
Extending production capabilities to the Americas helps reduce labor costs and inventory complexity for nutraceuticals and other industries while maintaining superior moisture control
Denosumab biosimilars approved in Canada to expand access for osteoporosis and cancer-related bone conditions
Veteran pharma leader brings 33+ years of experience to drive operational excellence in formulation business
The transition from an outsourced MRI model to an in-house facility marks more than an infrastructure upgrade
Aims to boost speed & precision in patient care
Subscribe To Our Newsletter & Stay Updated
_256_275.jpeg)
